Fluorodeoxyglucose–Positron-Emission Tomography, Single-Photon Emission Tomography, and Structural MR Imaging for Prediction of Rapid Conversion to Alzheimer Disease in Patients with Mild Cognitive Impairment: A Meta-Analysis

References

1. ↵
   Small GW, Rabins PV, Barry PP, et al. Diagnosis and treatment of Alzheimer disease and related disorders: Consensus statement of the American Association for Geriatric Psychiatry, the Alzheimer's Association, and the American Geriatrics Society. JAMA 1997;278:1363–71

   CrossRefPubMedWeb of Science
2. ↵
   DeCarli C. Mild cognitive impairment: prevalence, prognosis, aetiology, and treatment. Lancet Neurol 2003;2:15–21

   CrossRefPubMedWeb of Science
3. ↵
   Petersen RC, Stevens JC, Ganguli M, et al. Practice parameter: early detection of dementia—mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2001;56:1133–42

   Abstract/FREE Full Text
4. ↵
   Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol 2001;58:1985–92

   CrossRefPubMedWeb of Science
5. ↵
   Trikalinos TA, Salanti G, Zintzaras E, et al. Meta-analysis methods. Adv Genet 2008;60:311–34

   CrossRefPubMed
6. ↵
   Whiting P, Rutjes AWS, Reitsma JB, et al. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003;3:25

   CrossRefPubMed
7. ↵
   McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939–44

   Abstract/FREE Full Text
8. ↵
   American Psychiatric Association. American Psychiatric Association Committee on Nomenclature and Statistics: Diagnostic and Statistical Manual Of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press;1994
9. ↵
   Zamora J, Abraira V, Muriel A, et al. Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Med Res Methodol 2006;6:31

   CrossRefPubMed
10. ↵
    Chételat G, Desgranges B, de la Sayette V, et al. Mild cognitive impairment: can FDG-PET predict who is to rapidly convert to Alzheimer's disease? Neurology 2003;60:1374–77

    Abstract/FREE Full Text
11. ↵
    Anchisi D, Borroni B, Franceschi M, et al. Heterogeneity of brain glucose metabolism in mild cognitive impairment and clinical progression to Alzheimer disease. Arch Neurol 2005;62:1728–33

    CrossRefPubMedWeb of Science
12. ↵
    Arnaiz E, Jelic V, Almkvist O, et al. Impaired cerebral glucose metabolism and cognitive functioning predict deterioration in mild cognitive impairment. Neuroreport 2001;12:851–55

    CrossRefPubMedWeb of Science
13. ↵
    Mosconi L, Perani D, Sorbi S, et al. MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET. Neurology 2004;63:2332–40

    Abstract/FREE Full Text
14. ↵
    Drzezga A, Grimmer T, Riemenschneider M, et al. Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. J Nucl Med 2005;46:1625–32

    Abstract/FREE Full Text
15. ↵
    Silverman DHS, Truong CT, Kim SK, et al. Prognostic value of regional cerebral metabolism in patients undergoing dementia evaluation: comparison to a quantifying parameter of subsequent cognitive performance and to prognostic assessment without PET. Mol Genet Metab 2003;80:350–55

    CrossRefPubMedWeb of Science
16. ↵
    Borroni B, Anchisi D, Paghera B, et al. Combined 99mTc-ECD SPECT and neuropsychological studies in MCI for the assessment of conversion to AD. Neurobiol Aging 2006;27:24–31. Epub 2005 Mar 24

    CrossRefPubMedWeb of Science
17. ↵
    Ishiwata A, Sakayori O, Minoshima S, et al. Preclinical evidence of Alzheimer changes in progressive mild cognitive impairment: a qualitative and quantitative SPECT study. Acta Neurol Scand 2006;114:91–96

    CrossRefPubMed
18. Johnson KA, Jones K, Holman BL, et al. Preclinical prediction of Alzheimer's disease using SPECT. Neurology 1998;50:1563–71

    Abstract/FREE Full Text
19. Encinas M, de Juan R, Marcos A, et al. Regional cerebral blood flow assessed with 99mTc-ECD SPECT as a marker of progression of mild cognitive impairment to Alzheimer's disease. Eur J Nucl Med Mol Imaging 2003;30:1473–80. Epub 2003 Aug 15

    CrossRefPubMedWeb of Science
20. O'Mahony D, Coffey J, Murphy J, et al. The discriminant value of semiquantitative SPECT data in mild Alzheimer's disease. J Nucl Med 1994;35:1450–55

    Abstract/FREE Full Text
21. ↵
    Hirao K, Ohnishi T, Hirata Y, et al. The prediction of rapid conversion to Alzheimer's disease in mild cognitive impairment using regional cerebral blood flow SPECT. Neuroimage 2005;28:1014–21

    CrossRefPubMedWeb of Science
22. ↵
    Huang C, Wahlund L, Almkvist O, et al. Voxel- and VOI-based analysis of SPECT CBF in relation to clinical and psychological heterogeneity of mild cognitive impairment. Neuroimage 2003;19:1137–44

    CrossRefPubMedWeb of Science
23. ↵
    Huang C, Wahlund L, Svensson L, et al. Cingulate cortex hypoperfusion predicts Alzheimer's disease in mild cognitive impairment. BMC Neurol 2002;2:9–14

    CrossRefPubMed
24. Galton CJ, Erzincxlioglu S, Sahakian BJ, et al. A comparison of the Addenbrooke's Cognitive Examination (ACE), conventional neuropsychological assessment, and simple MRI-based medial temporal lobe evaluation in the early diagnosis of Alzheimer's disease. Cogn Behav Neurol 2005;18:144–50

    CrossRefPubMedWeb of Science
25. Convit A, Asis J, Leon MJ, et al. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non-demented elderly predicts decline to Alzheimer's disease. Neurobiol Aging 2000;21:19–26

    PubMedWeb of Science
26. Devanand DP, Pradhaban G, Liu X, et al. Hippocampal and entorhinal atrophy in mild cognitive impairment prediction of Alzheimer disease. Neurology 2007;68:828–36

    Abstract/FREE Full Text
27. ↵
    Geroldi C, Rossi R, Calvagna C, et al. Medial temporal atrophy but not memory deficit predicts progression to dementia in patients with mild cognitive impairment. J Neurol Neurosurg Psychiatry 2006;77:1219–22

    Abstract/FREE Full Text
28. ↵
    Visser PJ, Scheltens P, Verhey FRJ, et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol 1999;246:477–85

    CrossRefPubMedWeb of Science
29. ↵
    Korf ESC, Wahlund L, Visser PJ, et al. Medial temporal lobe atrophy on MRI predicts dementia in patients with mild cognitive impairment. Neurology 2004;63:94–100

    Abstract/FREE Full Text
30. ↵
    Visser PJ, Verhey FRJ, Hofman PAM, et al. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J Neurol Neurosurg Psychiatry 2002;72:491–97

    Abstract/FREE Full Text
31. Dickerson BC, Goncharova I, Sullivan MP, et al. MRI derived entorhinal and hippocampal atrophy in incipient and very mild Alzheimer's disease. Neurobiol Aging 2001;22:747–54

    CrossRefPubMedWeb of Science
32. ↵
    Teipel SJ, Born C, Ewers M, et al. Multivariate deformation-based analysis of brain atrophy to predict Alzheimer's disease in mild cognitive impairment. Neuroimage 2007;38:13–24

    CrossRefPubMedWeb of Science
33. ↵
    Killiany RJ, Gomez-Isla T, Moss M, et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 2000;47:430–39

    CrossRefPubMedWeb of Science
34. ↵
    Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA 2001;285:914–24

    CrossRefPubMedWeb of Science
35. ↵
    Del Bo R, Scarlato M, Ghezzi S, et al. Is M129V of PRNP gene associated with Alzheimer's disease? A case-control study and a meta-analysis. Neurobiol Aging 2006;27:770.e1–770.e5. Epub 2005 Aug 15
36. ↵
    Koster MN, Dermaut B, Cruts M, et al. The alpha2-macroglobulin gene in AD: a population-based study and meta-analysis. Neurology 2000;55:678–84

    Abstract/FREE Full Text
37. ↵
    Grégoire G, Derderian F, Le Lorier J. Selecting the language of the publications included in a meta-analysis: is there a Tower of Babel bias? J Clin Epidemiol 1995;48:159–63

    CrossRefPubMedWeb of Science
38. ↵
    Petersen RC, Smith GE, Waring SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–08

    CrossRefPubMedWeb of Science
39. ↵
    Karas G, Sluimer J Goekoop R, et al. Amnestic mild cognitive impairment: structural MR imaging findings predictive of conversion to Alzheimer disease. AJNR Am J Neuroradiol 2008;29:944–49

    Abstract/FREE Full Text